Molecular modelling of mebendazole polymorphs as a potential colchicine binding site inhibitor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular modelling of mebendazole polymorphs as a potential colchicine binding site inhibitor

Published:2020 Issue:33 Volume:44 Page:13990-13996
ISSN:1144-0546
Container-title:New Journal of Chemistry
language:en
Short-container-title:New J. Chem.

Author:

Al-Karmalawy Ahmed A.¹²³⁴⁵^ORCID,Khattab Muhammad⁶⁷⁸⁹⁵^ORCID

Affiliation:

1. Department of Medicinal Pharmaceutical Chemistry

2. Faculty of Pharmacy

3. Horus University-Egypt

4. New Damietta 34518

5. Egypt

6. Department of Chemistry of Natural and Microbial Products

7. Division of Pharmaceutical and Drug Industries

8. National Research Centre

9. Cairo

Abstract

Form B of mebendazole is the form expected to bind more efficiently with the colchicine binding site within the tubulin protein.

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,General Chemistry,Catalysis

Link

http://pubs.rsc.org/en/content/articlepdf/2020/NJ/D0NJ02844D

Reference26 articles.

1. Use of Crystal Structure Informatics for Defining the Conformational Space Needed for Predicting Crystal Structures of Pharmaceutical Molecules

2. Recent progress of structural study of polymorphic pharmaceutical drugs

3. Diagnosing the decline in pharmaceutical R&D efficiency

4. The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development

5. Clinical development success rates for investigational drugs

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of benzimidazole-2-amide BNZ-111 as new tubulin inhibitor;Bioorganic & Medicinal Chemistry Letters;2024-11

2. In Silico Comparison of Main Proteinase Inhibitors for Different Coronaviruses;Baghdad Science Journal;2024-08-01

3. Computational studies of pyrimidine derivatives as inhibitors of human σ1 receptor using 3D-QSAR analysis, molecular docking, ADMET properties and DFT investigation;Chemical Physics Impact;2024-06

4. Chiral Hydroxy Metabolite of Mebendazole: Analytical and Semi-Preparative High-Performance Liquid Chromatography Resolution and Chiroptical Properties;Pharmaceuticals;2024-05-28

5. Design and synthesis of novel tetrabromophthalimide derivatives as potential tubulin inhibitors endowed with apoptotic induction for cancer treatment;Drug Development Research;2024-05-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3